LLY

NYSE

ELI LILLY & Co

Latest disclosureSeptember 22, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 6 sales

Price by TradingView

Insider transactions 37

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 20 trades on this page.

Award disclosed

Gabrielle Sulzberger

Director

Common Stock

Value context: $4.96K
Reported price: $1,164.89 / share

Award disclosed

Juan R. Luciano

Director

Common Stock

Value context: $15.92K
Reported price: $1,164.89 / share

Award disclosed

J. Erik Fyrwald

Director

Common Stock

Value context: $9.92K
Reported price: $1,164.89 / share

Award disclosed

Ralph Alvarez

Director

Common Stock

Value context: $12.42K
Reported price: $1,164.89 / share

Gift disclosed

Melissa Seymour

EVP, Global Quality

Common Stock

Value context: Not a purchase
Reported price: Gift · no purchase price

Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Gift disclosed

Melissa Seymour

EVP, Global Quality

Common Stock

Value context: Not a purchase
Reported price: Gift · no purchase price

Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Gift disclosed

Edgardo Hernandez

EVP & Pres., Mfg. Operations

Common Stock

Value context: Not a purchase
Reported price: Gift · no purchase price

Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Gift disclosed

Eric Dozier

EVP, Chief People Officer

Common Stock

Value context: Not a purchase
Reported price: Gift · no purchase price

Understand this price

The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.

Award disclosed

Gabrielle Sulzberger

Director

Common Stock

Value context: $4.96K
Reported price: $1,183.16 / share

Award disclosed

Juan R. Luciano

Director

Common Stock

Value context: $15.92K
Reported price: $1,183.16 / share

Award disclosed

J. Erik Fyrwald

Director

Common Stock

Value context: $9.92K
Reported price: $1,183.16 / share

Award disclosed

Ralph Alvarez

Director

Common Stock

Value context: $12.42K
Reported price: $1,183.16 / share

Exercise or conversion

Melissa Seymour

EVP, Global Quality

Common Stock

Value context: Not established
Reported price: $0 reported · see filing

Understand this price

The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.

Tax or exercise withholding

Melissa Seymour

EVP, Global Quality

Common Stock

Value context: $504K
Reported price: $1,148.84 / share

Exercise or conversion

Melissa Seymour

EVP, Global Quality

Restricted Stock Unit

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: Exercise / conversion price not reported

Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Award disclosed

Gabrielle Sulzberger

Director

Common Stock

Value context: $4.96K
Reported price: $1,146.90 / share

Award disclosed

Juan R. Luciano

Director

Common Stock

Value context: $15.92K
Reported price: $1,146.90 / share

Award disclosed

J. Erik Fyrwald

Director

Common Stock

Value context: $9.92K
Reported price: $1,146.90 / share

Award disclosed

Ralph Alvarez

Director

Common Stock

Value context: $12.42K
Reported price: $1,146.90 / share

Award disclosed

Gabrielle Sulzberger

Director

Common Stock

Value context: $4.96K
Reported price: $1,129.35 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Common StockGrant or award	4$1,164.89 / share	$4.96K	Sep 21Filed Sep 22 · 1d later	SEC filing
Director	Common StockGrant or award	14$1,164.89 / share	$15.92K	Sep 21Filed Sep 22 · 1d later	SEC filing
Director	Common StockGrant or award	9$1,164.89 / share	$9.92K	Sep 21Filed Sep 22 · 1d later	SEC filing
Director	Common StockGrant or award	11$1,164.89 / share	$12.42K	Sep 21Filed Sep 22 · 1d later	SEC filing
EVP, Global Quality	Common StockGift	17Gift · no purchase price	Not a purchase	Sep 22Filed Sep 11 · 354d later	SEC filing
EVP, Global Quality	Common StockGift	12Gift · no purchase price	Not a purchase	Sep 9Filed Sep 11 · 2d later	SEC filing
EVP & Pres., Mfg. Operations	Common StockGift	13Gift · no purchase price	Not a purchase	Sep 2Filed Sep 4 · 2d later	SEC filing
EVP, Chief People Officer	Common StockGift	216Gift · no purchase price	Not a purchase	Sep 2Filed Sep 4 · 2d later	SEC filing
Director	Common StockGrant or award	4$1,183.16 / share	$4.96K	Aug 17Filed Aug 18 · 1d later	SEC filing
Director	Common StockGrant or award	13$1,183.16 / share	$15.92K	Aug 17Filed Aug 18 · 1d later	SEC filing
Director	Common StockGrant or award	8$1,183.16 / share	$9.92K	Aug 17Filed Aug 18 · 1d later	SEC filing
Director	Common StockGrant or award	10$1,183.16 / share	$12.42K	Aug 17Filed Aug 18 · 1d later	SEC filing
EVP, Global Quality	Common StockOption exercise or conversion	981$0 reported · see filing	Not established	Aug 1Filed Aug 3 · 2d later	SEC filing
EVP, Global Quality	Common StockExercise-price or tax withholding	439$1,148.84 / share	$504K	Aug 1Filed Aug 3 · 2d later	SEC filing
EVP, Global Quality	Restricted Stock UnitOption exercise or conversion	Derivative units981Exercise / conversion price not reported	Not a separate purchase	Aug 1Filed Aug 3 · 2d later	SEC filing
Director	Common StockGrant or award	4$1,146.90 / share	$4.96K	Jul 20Filed Jul 21 · 1d later	SEC filing
Director	Common StockGrant or award	14$1,146.90 / share	$15.92K	Jul 20Filed Jul 21 · 1d later	SEC filing
Director	Common StockGrant or award	9$1,146.90 / share	$9.92K	Jul 20Filed Jul 21 · 1d later	SEC filing
Director	Common StockGrant or award	11$1,146.90 / share	$12.42K	Jul 20Filed Jul 21 · 1d later	SEC filing
Director	Common StockGrant or award	4$1,129.35 / share	$4.96K	Jun 15Filed Jun 16 · 1d later	SEC filing

Showing the latest 20 of 31 trades. Show all 31 trades

Congress transactions 26

All Congress filings

Partial sale disclosedAmended report

Eli Lilly and Company · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 21, 2025

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 1, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 2, 2026

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

Michael RulliReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 2, 2025

Full sale disclosedAmended report

Eli Lilly and Company · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: April 15, 2025

Full sale disclosed

Eli Lilly and Company Common Stock · Stock

The filing reports a full sale for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for a spouse.

Dan NewhouseReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 10, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $50,001 – $100,000Reported range; exact amount not disclosed.
Trade date: June 10, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for a spouse.

Byron DonaldsReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 2, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Byron DonaldsReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 2, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 14, 2026

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for the member.

Elizabeth FletcherReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 8, 2026

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 13, 2026

Full sale disclosed

Eli Lilly and Company Common Stock · Stock

The filing reports a full sale for a spouse.

Angus S King Jr.Reporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 13, 2026

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 26, 2026

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 9, 2026

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 16, 2026

Purchase disclosed

Eli Lilly and Company · Stock

The filing reports a purchase for a spouse.

Angus S King Jr.Reporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Purchase disclosed

Eli Lilly and Company Common Stock · Stock

The filing reports a purchase for a joint account.

Markwayne MullinReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: December 29, 2025

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a sale for the member.

David J. TaylorReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 10, 2025

Purchase disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 18, 2025

Partial sale disclosed

Eli Lilly and Company Common Stock (LLY) · Stock

The filing reports a partial sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Partial sale disclosed

Eli Lilly and Company · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 21, 2025

Purchase disclosed

Eli Lilly and Company · Stock

The filing reports a purchase for a spouse.

Shelley M CapitoReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 24, 2025

Showing the latest 25 of 26 disclosed trades. Show all 26 trades

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000059478
Latest public acceptance: Sep 22, 2026, 08:15 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Director

Common StockGrant or award

4$1,164.89 / share

$4.96K

Sep 21Filed Sep 22 · 1d later

SEC filing

Director

Common StockGrant or award

14$1,164.89 / share

$15.92K

Sep 21Filed Sep 22 · 1d later

SEC filing

Director

Common StockGrant or award

9$1,164.89 / share

$9.92K

Sep 21Filed Sep 22 · 1d later

SEC filing

Director

Common StockGrant or award

11$1,164.89 / share

$12.42K

Sep 21Filed Sep 22 · 1d later

SEC filing

EVP, Global Quality

Common StockGift

17Gift · no purchase price

Not a purchase

Sep 22Filed Sep 11 · 354d later

SEC filing

EVP, Global Quality

Common StockGift

12Gift · no purchase price

Not a purchase

Sep 9Filed Sep 11 · 2d later

SEC filing

EVP & Pres., Mfg. Operations

Common StockGift

13Gift · no purchase price

Not a purchase

Sep 2Filed Sep 4 · 2d later

SEC filing

EVP, Chief People Officer

Common StockGift

216Gift · no purchase price

Not a purchase

Sep 2Filed Sep 4 · 2d later

SEC filing

Director

Common StockGrant or award

4$1,183.16 / share

$4.96K

Aug 17Filed Aug 18 · 1d later

SEC filing

Director

Common StockGrant or award

13$1,183.16 / share

$15.92K

Aug 17Filed Aug 18 · 1d later

SEC filing

Director

Common StockGrant or award

8$1,183.16 / share

$9.92K

Aug 17Filed Aug 18 · 1d later

SEC filing

Director

Common StockGrant or award

10$1,183.16 / share

$12.42K

Aug 17Filed Aug 18 · 1d later

SEC filing

EVP, Global Quality

Common StockOption exercise or conversion

981$0 reported · see filing

Not established

Aug 1Filed Aug 3 · 2d later

SEC filing

EVP, Global Quality

Common StockExercise-price or tax withholding

439$1,148.84 / share

$504K

Aug 1Filed Aug 3 · 2d later

SEC filing

EVP, Global Quality

Restricted Stock UnitOption exercise or conversion

Derivative units981Exercise / conversion price not reported

Not a separate purchase

Aug 1Filed Aug 3 · 2d later

SEC filing

Director

Common StockGrant or award

4$1,146.90 / share

$4.96K

Jul 20Filed Jul 21 · 1d later

SEC filing

Director

Common StockGrant or award

14$1,146.90 / share

$15.92K

Jul 20Filed Jul 21 · 1d later

SEC filing

Director

Common StockGrant or award

9$1,146.90 / share

$9.92K

Jul 20Filed Jul 21 · 1d later

SEC filing

Director

Common StockGrant or award

11$1,146.90 / share

$12.42K

Jul 20Filed Jul 21 · 1d later

SEC filing

Director

Common StockGrant or award

4$1,129.35 / share

$4.96K

Jun 15Filed Jun 16 · 1d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000059478
Latest public acceptance: Sep 22, 2026, 08:15 PM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.